Evidence map›Paper›PMID 36261268›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2022

History of Previous Midlife Estradiol Treatment Permanently Alters Interactions of Brain Insulin-like Growth Factor-1 Signaling and Hippocampal Estrogen Synthesis to Enhance Cognitive Aging in a Rat Model of Menopause.

Nina E Baumgartner, Shannon M McQuillen, Samantha F Perry, Sangtawan Miller, Matthieu J Maroteaux, Robert B Gibbs, Jill M Daniel

Open access · hybridAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Estrogen Alleviates Sevoflurane-Induced Neurotoxicity by Inhibiting ERα-Tau Binding.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Nina E BaumgartnerBrain Institute nbaumgar@tulane.edu.
Shannon M McQuillenBrain Institute.
Samantha F PerryBrain Institute.
Sangtawan MillerBrain Institute.
Matthieu J MaroteauxBrain Institute.
Robert B GibbsDepartment of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania 15261.
Jill M DanielBrain Institute.
Allen Institute for Brain Science · USSociety for Neuroscience · USUniversity of Pittsburgh · US

Funding

Short-term estradiol use in middle-age: implications for female cognitive agingRF1AG041374 · NIA · TULANE UNIVERSITY OF LOUISIANA · PI DANIEL, JILL M · 2018 to 2019
$2.3M
API 4000 QTRAPS10RR023461 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI POLOYAC, SAMUEL M · 2007 to 2007
$487k
Small Molecule Biomarker Core: TSQ Altis LC-MS/MSS10OD028540 · OD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NOLIN, THOMAS DOUGLAS · 2020 to 2020
$429k
NCRR NIH HHS S10 RR023461NIA NIH HHS RF1 AG041374NIH HHS S10 OD028540
6 · The paper itself

Abstract

Across species, including humans, elevated levels of brain estrogen receptor (ER) α are associated with enhanced cognitive aging, even in the absence of circulating estrogens. In rodents, short-term estrogen treatment, such as that commonly used in the menopausal transition, results in long-term increases in ERα levels in the hippocampus, leading to enhanced memory long after termination of estrogen treatment. However, mechanisms by which increased levels of brain ERα enhances cognitive aging remain unclear. Here we demonstrate in aging female rats that insulin-like growth factor-1 (IGF-1), which can activate ER via ligand-independent mechanisms, requires concomitant synthesis of brain-derived neuroestrogens to phosphorylate ERα via MAPK signaling, ultimately resulting in enhanced memory. In a rat model of menopause involving long-term ovarian hormone deprivation, hippocampal neuroestrogen activity decreases, altering IGF-1 activity and resulting in impaired memory. However, this process is reversed by short-term estradiol treatment. Forty days of estradiol exposure following ovariectomy results in maintenance of neuroestrogen levels that persist beyond the period of hormone treatment, allowing for continued interactions between IGF-1 and neuroestrogen signaling, elevated levels of hippocampal ERα, and ultimately enhanced memory. Collectively, results demonstrate that short-term estradiol use following loss of ovarian function has long-lasting effects on hippocampal function and memory by dynamically regulating cellular mechanisms that promote activity of ERα in the absence of circulating estrogens. Translational impacts of these findings suggest lasting cognitive benefits of short-term estrogen use near menopause and highlight the importance of hippocampal ERα, independent from the role of circulating estrogens, in regulating memory in aging females.

Indexed as

Cognitive AgingEstradiolAgingAnimalsBrainEstrogen Receptor alphaEstrogensFemaleHippocampusHumansInsulin-Like Growth Factor ILigandsMenopauseRatsReceptors, EstrogenEstradiolEstrogen Receptor alphaEstrogensInsulin-Like Growth Factor ILigandsReceptors, EstrogenagingestrogenhippocampusIGF-1memorymenopause

Identifiers

PMID36261268
PMCPMC9617614
OpenAlexW4294844769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.